Literature DB >> 22894629

Treatment of hypertension in diabetes: what is the best therapeutic option?

Tonje A Aksnes1, Sigrid N Skårn, Sverre E Kjeldsen.   

Abstract

Patients with diabetes mellitus have a high risk of cardiovascular disease, and the latter is the leading cause of premature mortality in diabetic patients. Treatment of risk factors and comorbidities, such as hypertension, is very important and may effectively prevent cardiovascular events. The blood pressure goal in diabetic patients should be below 140/90 mmHg, probably down to 130-135/85 mmHg, although the evidence for this is scarce. To reach this blood pressure goal, intensive lifestyle intervention and often combinations of different antihypertensive drugs must be initiated. In combination treatment, a blocker of the renin-angiotensin system should be included, and according to the results of the ACCOMPLISH trial, a combination of a renin-angiotensin system blocker and a calcium channel blocker should probably be the first choice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894629     DOI: 10.1586/erc.12.59

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  6 in total

1.  Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial.

Authors:  Fatemeh Rahimi; Yahya Pasdar; Mojtaba Kaviani; Soheil Abbasi; Hillary Fry; Azita Hekmatdoost; Omid Nikpayam; Golbon Sohrab; Mansoaur Rezaei; Seyed Mostafa Nachvak; Reza Mohammadi
Journal:  Int J Clin Pract       Date:  2022-04-16       Impact factor: 3.149

Review 2.  Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.

Authors:  Daniel Lorber
Journal:  Diabetes Metab Syndr Obes       Date:  2014-05-23       Impact factor: 3.168

3.  Correlation between Diastolic Function and Endothelial Function in Patients with Type 2 Diabetes and Hypertension.

Authors:  Ricardo Bedirian; Mario Fritsch Neves; Wille Oigman; Ronaldo Altenburg Odebrecht Curi Gismondi; Cesar Romaro Pozzobon; Marcia Cristina Boaventura Ladeira; Marcia Bueno Castier
Journal:  Open Cardiovasc Med J       Date:  2016-10-31

4.  Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study.

Authors:  Hae Jin Kim; Seung Jin Han; Dae Jung Kim; Hak Chul Jang; Soo Lim; Sung Hee Choi; Yong Hyun Kim; Dong Hyun Shin; Se Hwa Kim; Tae Ho Kim; Yu Bae Ahn; Seung Hyun Ko; Nan Hee Kim; Ji A Seo; Ha Young Kim; Kwan Woo Lee
Journal:  Korean J Intern Med       Date:  2016-12-30       Impact factor: 2.884

5.  Antihypertensive drugs use over a 5-year period among children and adolescents in Beijing, China: An observational study.

Authors:  Yao Wu; Yaying Cao; Jing Song; Yaohua Tian; Mengying Wang; Man Li; Xiaowen Wang; Zhe Huang; Lin Li; Yaling Zhao; Xueying Qin; Yonghua Hu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

Review 6.  Renin inhibitors in diabetes and hypertension: an update.

Authors:  Selcuk Sen; Baran Ufuktepe; Zeynep Günes Özünal; Yagiz Üresin
Journal:  EXCLI J       Date:  2014-09-24       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.